Shaping future today

What does true innovation look like? A pathbreaking ex-vivo tissue generating technology that is poised to become the next big thing in oncology. A naive antibody library that scores better than other platforms. Development of a breakthrough technology for oral delivery of insulin. Read on.


Axtex 4

3-D cell culture to enable rapid, combinatorial screens for targeted onco / immuno-oncology drug therapeutic candidates

3-D cell culture has multiple benefits over 2-D cell culture which has been recognized over the past decade. The limitations are the ability to produce rapid, reproducible scaffolds which can be rapidly deployed to screen multiple drugs, either alone or in combination of drugs. Most 3-D models have been complicated, highly varied in their response to adaption to assay formats and readouts. This causes significant difficulties to be able to be adapted to drug discovery and functional assays, especially for 96 well formats. Most 3-D models are 6 well models.